| Patents for C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465) |
|---|
| 03/13/2007 | CA2351049C Process for recovery of the desired cis-1,3-oxathiolane nucleosides from their undesired trans-isomers |
| 03/08/2007 | US20070054899 Aromatase inhibitor compounds and uses thereof |
| 03/07/2007 | CN1923832A Novel pyridazinone compound, preparation method and application thereof |
| 03/01/2007 | WO2005117882A9 Hydroxamic acid derivatives as metalloprotease inhibitors |
| 02/28/2007 | CN1920050A Method of resolution of 1,3-oxathiolane nucleoside enantiomers |
| 02/27/2007 | US7183295 Compound for treatment of lipemic agents, antiinflammatory agents and treatment of diabetes |
| 02/20/2007 | CA2180156C Self-assembled taxo-diperpenoid nanostructures |
| 02/15/2007 | US20070037977 Substituted-1, 3-oxathiolanes and substituted-1, 3-dioxolanes with antiviral properties |
| 02/15/2007 | US20070037975 Substituted-1,3-oxathiolanes and substituted-1, 3-dioxolanes with antiviral properties |
| 02/14/2007 | EP1534391B1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/06/2007 | US7173134 retinoid X receptors ("RXRs"); useful for the treatment of diabetes (NIDDIM) and obesity; for example, 3-{4-[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl]-2-furyl}-2-propenoic acid |
| 02/06/2007 | US7173129 Sulfonamide-substituted chalcone derivatives and their use to treat diseases |
| 01/31/2007 | CN1297553C Stereoselective methods for the preparation of nucleosides |
| 01/30/2007 | CA2297011C Sulfonamide derivatives as therapeutic or prophylactic agent for glomerulopathy |
| 01/18/2007 | WO2007006739A1 Benzoheterocyclylethylcarboxamide derivatives |
| 01/18/2007 | WO2007006547A1 Amide derivatives as kinase inhibitors |
| 01/17/2007 | CN1898210A 2-pyridinylethylcarboxamide derivatives and their use as fungicides |
| 01/17/2007 | CN1896064A Metabolites of ecteinascidin 743 |
| 01/17/2007 | CN1295228C Nitryl methylene derivatives and uses thereof |
| 01/11/2007 | US20070010563 Novel methods for the treatment of inflammatory diseases |
| 01/10/2007 | EP1740544A1 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides |
| 01/10/2007 | CN1891221A Combination therapy to treat hepatitis b virus |
| 01/09/2007 | US7160999 The nucleoside enantiomer (-)-2-hydroxymethyl-5-(5-fluorocytosin-1-yl) -1,3-oxathiolane is an effective antiviral agent against HIV, HBV, and other viruses replicating in a similar manner |
| 01/03/2007 | EP0958292B1 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides |
| 01/03/2007 | CN1293058C O-cyclopropyl-carboxanilides and their use as fungicides |
| 12/27/2006 | CN1886403A Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas |
| 12/26/2006 | US7153852 Skin disorders; antiinflammatory agents; brain disorders; chronic obstructive pulmonary disease; antiarthritic agents; inflammatory bowel disorders |
| 12/21/2006 | WO2005092856A8 Tetrahydrocarbazoles and derivatives |
| 12/21/2006 | US20060287361 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof as opoid receptors ligands |
| 12/21/2006 | US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 12/20/2006 | EP1732892A1 Tetrahydrocarbazoles and derivatives |
| 12/20/2006 | EP1732564A1 Biaryl substituted pyrazinones as sodium channel blockers |
| 12/20/2006 | EP1608644B8 Process and intermediates for preparing emtricitabine |
| 12/20/2006 | CN1290845C Process for synthesis of nucleoside analogue |
| 12/20/2006 | CN1290841C Process for the non-enantiomorph selective synthesis of nucleoside analogues |
| 12/14/2006 | WO2006073589A3 Cycloalkyl keto piperidine tachykinin receptor antagonists |
| 12/07/2006 | WO2006057977A3 Cycloalkyl piperidine tachykinin receptor antagonists |
| 12/07/2006 | US20060276492 Treating human immunodeficiency and hepatitis B infections; high activity, low toxicity |
| 12/07/2006 | US20060276434 3-Carbonylaminothiophenes and their use as fungicides |
| 12/06/2006 | CN1288157C Dioxadiene pyridine compounds for treating impaired fundic relaxation, method of preparation and use thereof |
| 11/30/2006 | WO2006125972A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 11/30/2006 | CA2609235A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 11/29/2006 | EP1725535A2 Hiv integrase inhibitors |
| 11/29/2006 | CN1871216A Inhibitors of cathepsin s |
| 11/28/2006 | CA2113603C Tricyclic condensed heterocyclic compounds, their production and use |
| 11/21/2006 | US7138426 Estrogen receptor modulators |
| 11/16/2006 | WO2005117882A3 Hydroxamic acid derivatives as metalloprotease inhibitors |
| 11/14/2006 | US7135495 Indole derivatives |
| 11/14/2006 | US7135479 Compounds which are both serotonin reuptake inhibitors and antagonists of the 5HT1A receptor |
| 11/09/2006 | WO2005079802A8 Bipyridyl amides as modulators of metabotropic glutamate receptor-5 |
| 11/02/2006 | US20060247189 Forms of 5-Azacytidine |
| 11/02/2006 | EP1715867A1 Bipyridyl amides as modulators of metabotropic glutamate receptor-5 |
| 11/02/2006 | EP1608644B1 Process and intermediates for preparing emtricitabine |
| 10/26/2006 | WO2006036941A3 Specific kinase inhibitors |
| 10/26/2006 | US20060241147 Pyridine derivatives useful for inhibiting sodium/calcium exchange system |
| 10/25/2006 | CN1281597C New compounds, which are potent inhibitors of Na<+>/Ca<2+> exchange mechanism and are useful in the treatment of arrhythmias |
| 10/24/2006 | CA2442615C A reduced ignition propensity smoking article |
| 10/24/2006 | CA2168023C Vasoconstrictive substituted aryloxyalkyl diamines |
| 10/19/2006 | WO2006109846A1 Triazole derivative and the use thereof |
| 10/19/2006 | WO2006108791A2 Heterocyclylethylheterocyclylcarboxamide derivatives as fungicides |
| 10/19/2006 | US20060234987 Neuroprotective benzo 1 3 oxathiol 2 ones |
| 10/17/2006 | US7122693 Acetaldehyde acetal compounds, their synthesis, and uses thereof |
| 10/11/2006 | CN1845673A Pyridinylanilides |
| 10/11/2006 | CN1279034C Dna－pk抑制剂 Dna-pk inhibitors |
| 10/10/2006 | US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 10/10/2006 | US7119202 Substituted-1,3-oxathiolanes and substituted-1,3-dioxolanes with antiviral properties |
| 10/05/2006 | WO2006103511A1 Cyclopentapyridine and tetrahydroquinoline derivatives |
| 10/03/2006 | US7115743 For treatment of leukemia, carcinomas, adenocarcinomas, and melanoma; assaying metabolism via cytochromes |
| 10/03/2006 | US7115661 Methods and compositions for mitigating pain |
| 09/28/2006 | US20060217379 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 09/27/2006 | EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/27/2006 | EP1383757B1 Antagonists of mcp-1 function and methods of use thereof |
| 09/21/2006 | WO2006096954A1 Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1´-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof |
| 09/20/2006 | EP0889889B1 Piperazine and piperidine compounds |
| 09/19/2006 | US7109334 Predominantly cis nucleosides or nucleoside analogues and derivatives from 2-oxymethyl- thiolane-S-oxide, oxathiolane-S-oxide or dithiolane-S-oxide and a pyridine, pyrimidine or triazine base |
| 09/19/2006 | US7109234 Benzoxathiepine derivatives and their use as medicines |
| 09/14/2006 | US20060205722 Such as N-{1-[2-(1,3-dioxan-2-yl)ethyl]piperidin-4-yl}-N-(4-fluorobenzyl)-2-[4-(2-hydroxy-2-methylpropoxy)phenyl]acetamide; selective inverse agonists of 5-HT2A receptor with minimal monamine receptors subtype activity; antipsychotics with reduced side effects |
| 09/13/2006 | CN1274687C Suitqable to industrialized method for preparing emtricitabine |
| 09/13/2006 | CN1274686C Suitable industrialized method of preparing Lamivudine |
| 09/08/2006 | WO2005086700A3 Hiv integrase inhibitors |
| 09/07/2006 | US20060199818 Inhibiting the activity of a 5-hydroxytryptamine 2A by administering a N-heterocyclyl (preferably 1,3-dioxan-5-yl)-4-[(N-substituted)(hetero)arylamino]piperidine in which the N-substituant is arylalkanoyl, arylthioalkanoyl, arylalkylaminocarbonyl or arylalkylaminothiocarbonyl group |
| 09/05/2006 | US7101867 Benzofuran derivatives, their production and use |
| 08/31/2006 | WO2006062984A3 Inhibitors of protein kinases |
| 08/30/2006 | EP1694649A1 2-pyridinylethylcarboxamide derivatives and their use as fungicides |
| 08/30/2006 | EP1412343B1 Compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
| 08/29/2006 | US7098234 Indole derivatives, process for preparation of the same and use thereof |
| 08/24/2006 | WO2006088711A1 AZOLYLACYLGUANIDINES AS β-SECRETASE INHIBITORS |
| 08/24/2006 | US20060189805 Characterized by the formation and isolation of intermediate compounds in salified form; by using the intermediate of the present process in the subsequent reductive passage, it is possible to obtain emtricitabine in a purity that allows its direct crystallization; viricides |
| 08/24/2006 | CA2597594A1 Azolylacylguanidines as beta-secretase inhibitors |
| 08/23/2006 | EP1693373A1 Enantiomerically pure beta-D-(-)-dioxolane-nucleosides |
| 08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
| 08/17/2006 | US20060183899 Having a predominantly cis configuration by coupling an S-oxide of a 2-oxymethyl- thiolane, dithiolane or oxathiolane with a nucleoside base in the presence of a tertiary amine, a Lewis acid of a Group 1B or 2B metal catalyst and deprotecting the intermediate formed |
| 08/17/2006 | US20060183749 Novel compounds and methods of treating cell proliferative diseases, retinopathies and arthritis |
| 08/10/2006 | WO2006062982A3 Urea inhibitors of map kinases |
| 08/10/2006 | US20060178513 Pyridinylanilides |
| 08/09/2006 | EP1687301A1 Thiaepothilone for treating cancerous diseases |
| 08/09/2006 | EP1597253B1 Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis |
| 08/03/2006 | WO2006051477A3 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha |
| 08/03/2006 | CA2595855A1 Pyrazine compounds for inflammation and immune-related uses |